Targeting miR-126 disrupts maintenance of myelodysplastic syndrome stem and progenitor cells.
Wang H, Sun J, Zhang B, Zhao D, Tong H, Wu H, Li X, Luo Y, Dong D, Yao Y, McDonald T, Stein AS, Al Malki MM, Pichiorri F, Carlesso N, Kuo YH, Marcucci G, Li L, Jin J.
Wang H, et al. Among authors: jin j.
Clin Transl Med. 2021 Oct;11(10):e610. doi: 10.1002/ctm2.610.
Clin Transl Med. 2021.
PMID: 34709739
Free PMC article.